Visionary Holdings and Jiangsu Yike Regenerative Medical Technology Establish Joint Venture to Commercialize Stem Cell Therapy for Diabetes Remission in $150 Billion Market

Jinxin Technology Holding Company announced a $2 million share repurchase program, allowing the company to repurchase its ordinary shares until October 21, 2026. The repurchases may be made through open market purchases, privately negotiated transactions, or block trades, depending on market conditions. The company's board of directors will review the program periodically and may adjust its terms, suspend or discontinue it at any time. The repurchases will be funded by the company's existing cash balance.